Change search
ReferencesLink to record
Permanent link

Direct link
A novel role for phospholipase D as an endogenous negative regulator of platelet sensitivity
University of Tubingen, Germany .
Linköping University, Department of Medical and Health Sciences, Pharmacology. Linköping University, Faculty of Health Sciences.
Linköping University, Department of Clinical and Experimental Medicine, Clinical Chemistry. Linköping University, Faculty of Health Sciences.
University of Tubingen, Germany .
Show others and affiliations
2012 (English)In: Cellular Signalling, ISSN 0898-6568, E-ISSN 1873-3913, Vol. 24, no 9, 1743-1752 p.Article in journal (Refereed) Published
Abstract [en]

Platelet aggregation, secretion and thrombus formation play a critical role in primary hemostasis to prevent excessive blood loss. On the other hand, uncontrolled platelet activation leads to pathological thrombus formation resulting in myocardial infarction or stroke. Stimulation of heterotrimeric G-proteins by soluble agonists or immunoreceptor tyrosine based activation motif-coupled receptors that interact with immobilized ligands such as the collagen receptor glycoprotein (GP) VI lead to the activation of phospholipases that cleave membrane phospholipids to generate soluble second messengers. Platelets contain the phospholipases (PL) D1 and D2 which catalyze the hydrolysis of phosphatidylcholine to generate the second messenger phosphatidic acid (PA). The production of PA is abrogated by primary alcohols that have been widely used for the analysis of PLD-mediated processes. However, it is not clear if primary alcohols effectively reduce PA generation or if they induce PLD-independent cellular effects. In the present study we made use of the specific PLD inhibitor 5-fluoro-2-indolyl des-chlorohalopemide (FIPI) and show for the first time, that FIPI enhances platelet dense granule secretion and aggregation of human platelets. Further. FIPI has no effect on cytosolic Ca2+ activity but needs proper Rho kinase signaling to mediate FIPI-induced effects on platelet activation. Upon FIPI treatment the phosphorylation of the PKC substrate pleckstrin was prominently enhanced suggesting that FIPI affects PKC-mediated secretion and aggregation in platelets. Similar effects of FIPI were observed in platelets from mouse wild-type and Pld1(-/-) mice pointing to a new role for PLD2 as a negative regulator of platelet sensitivity.

Place, publisher, year, edition, pages
Elsevier , 2012. Vol. 24, no 9, 1743-1752 p.
Keyword [en]
PLD; Platelets; Secretion; Aggregation; Regulation
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-80685DOI: 10.1016/j.cellsig.2012.04.018ISI: 000306621000003OAI: diva2:547904
Available from: 2012-08-29 Created: 2012-08-29 Last updated: 2012-09-06

Open Access in DiVA

fulltext(504 kB)324 downloads
File information
File name FULLTEXT01.pdfFile size 504 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Grenegård, MagnusLindahl, TomasFälker, Knut
By organisation
PharmacologyFaculty of Health SciencesClinical ChemistryDepartment of Clinical ChemistryDepartment of Clinical and Experimental Medicine
In the same journal
Cellular Signalling
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 324 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 122 hits
ReferencesLink to record
Permanent link

Direct link